BACKGROUND: Urothelial bladder cancers (UBCs) are distinct in two main molecular subtypes, namely basal and luminal type. Subtypes are also diverse in term of immune contexture, providing a rationale for patient selection to immunotherapy. METHODS: By digital microscopy analysis of a muscle-invasive BC (MIBC) cohort, we explored the density and clinical significance of CD66b RESULTS: Basal type BC contained a significantly higher density of CD66b CONCLUSIONS: TAN are recruited in basal type MIBC by pro-inflammatory CKs. This finding establishes a groundwork for a better understanding of the UBC immunity and its relevance
SummaryMuscle-invasive bladder cancers (MIBCs) are biologically heterogeneous and have widely variab...
Current literature suggested that the role of tumour infiltrating neutrophils could be pro- or anti-...
: Bladder cancer (BlCa) is a highly immunogenic cancer. Bacillus Calmette-Guérin (BCG) is the standa...
Background: Urothelial bladder cancers (UBCs) are distinct in two main molecular subtypes, namely ba...
Despite the advances in systemic immunotherapy with immune checkpoint blockade, only a small fractio...
Immunotherapy, especially anti-PD-1, is becoming a pillar of modern muscle-invasive bladder cancer (...
Purpose: To establish whether the expression of markers of cell differentiation (CK7, CK14, CK20, GA...
Background: It has been suggested that bladder cancer can be divided into two molecular subtypes ref...
IntroductionMuscle-invasive bladder cancer (MIBC) is a heterogeneous disease with several taxonomic ...
IntroductionMuscle-invasive bladder cancer (MIBC) is a heterogeneous disease with several taxonomic ...
Despite the advances in cancer immunotherapy, only a fraction of patients with bladder cancer exhibi...
Background: Immunotherapies including PD-1/PD-L1 antibodies have been approved for the treatment of ...
Urinary bladder cancer is the ninth most common malignancy, with ~77,000 new cases and ~16,000 death...
IntroductionMuscle-invasive bladder cancer (MIBC) is a heterogeneous disease with several taxonomic ...
BACKGROUND: Although various molecular subtypes of bladder cancer (BC) have been investigated, mos...
SummaryMuscle-invasive bladder cancers (MIBCs) are biologically heterogeneous and have widely variab...
Current literature suggested that the role of tumour infiltrating neutrophils could be pro- or anti-...
: Bladder cancer (BlCa) is a highly immunogenic cancer. Bacillus Calmette-Guérin (BCG) is the standa...
Background: Urothelial bladder cancers (UBCs) are distinct in two main molecular subtypes, namely ba...
Despite the advances in systemic immunotherapy with immune checkpoint blockade, only a small fractio...
Immunotherapy, especially anti-PD-1, is becoming a pillar of modern muscle-invasive bladder cancer (...
Purpose: To establish whether the expression of markers of cell differentiation (CK7, CK14, CK20, GA...
Background: It has been suggested that bladder cancer can be divided into two molecular subtypes ref...
IntroductionMuscle-invasive bladder cancer (MIBC) is a heterogeneous disease with several taxonomic ...
IntroductionMuscle-invasive bladder cancer (MIBC) is a heterogeneous disease with several taxonomic ...
Despite the advances in cancer immunotherapy, only a fraction of patients with bladder cancer exhibi...
Background: Immunotherapies including PD-1/PD-L1 antibodies have been approved for the treatment of ...
Urinary bladder cancer is the ninth most common malignancy, with ~77,000 new cases and ~16,000 death...
IntroductionMuscle-invasive bladder cancer (MIBC) is a heterogeneous disease with several taxonomic ...
BACKGROUND: Although various molecular subtypes of bladder cancer (BC) have been investigated, mos...
SummaryMuscle-invasive bladder cancers (MIBCs) are biologically heterogeneous and have widely variab...
Current literature suggested that the role of tumour infiltrating neutrophils could be pro- or anti-...
: Bladder cancer (BlCa) is a highly immunogenic cancer. Bacillus Calmette-Guérin (BCG) is the standa...